Useful links
Unit of study_
MBHT5004: Cardiovascular Metabolic Management
2024 unit information
This unit will enhance students' understanding of cardiovascular risk factors and common cardiovascular complications of metabolic disease. It will facilitate increased confidence in the screening and assessment, diagnosis, prevention and practical management of cardiovascular disease in its broadest sense. The epidemiology and pathophysiology of atherogenesis and cardiovascular disease will be explored, followed by an in-depth exploration of the characterisation and patient-centred management of standard modifiable cardiovascular risk factors including hypertension, lipid and lipoprotein disorders, diabetes, and lifestyle factors pertinent to cardiovascular health. Evidence-based screening and diagnosis, lifestyle interventions, pharmacotherapy and non-invasive screening and assessment will be covered. This will be followed by a detailed exploration of large and small vessel disease and the implications of metabolic disease within the brain, kidney and heart (with a focus on ischaemic cardiomyopathy, diabetic cardiomyopathy and hypertensive cardiomyopathy). Peripheral arterial disease, cerebrovascular disease, arrhythmogenic disturbances, sleep disorders and non-alcoholic fatty liver disease will also be explored. At the conclusion of this unit of study, students will possess the knowledge and skills to assess and manage cardiovascular disease risk and have a comprehensive understanding of the potential cardiovascular complications of metabolic disease and knowledge of evidence-based strategies to improve clinical outcomes.
Unit details and rules
Managing faculty or University school:
Metabolic Health
| Code | MBHT5004 |
|---|---|
| Academic unit | Metabolic Health |
| Credit points | 6 |
|
Prerequisites:
?
|
None |
|---|---|
|
Corequisites:
?
|
None |
| Prohibitions:
?
|
None |
| Assumed knowledge:
?
|
This unit is intended for students who have experience in clinical care of patients and includes a significant Pharmacology component |
At the completion of this unit, you should be able to:
- LO1. outline the important pathophysiology that contributes to atherogenesis
- LO2. explain the implications of metabolic disease for cardiovascular risk
- LO3. describe traditional and novel risk factors for cardiovascular disease and demonstrate a thorough understanding of how to assess cardiovascular risk in the clinical setting
- LO4. implement primary and secondary prevention management plans to address cardiovascular risk factors including hypertension, hypercholesterolaemia and smoking
- LO5. describe basic coronary artery anatomy and the manifestations of stable and unstable coronary artery disease
- LO6. initiate an appropriate initial management plan for a patient with acute chest pain and identify those that need an emergency referral
- LO7. assess the long-term treatment considerations for people with documented coronary artery disease
- LO8. Identify the links between metabolic disease, heart failure and arrhythmia and institute appropriate investigations and management for the breathless patient
- LO9. describe the clinical manifestations of cerebrovascular and peripheral vascular disease and prepare a plan for best-practice management.
Unit availability
This section lists the session, attendance modes and locations the unit is available in. There is a unit outline for each of the unit availabilities, which gives you information about the unit including assessment details and a schedule of weekly activities.
The outline is published 2 weeks before the first day of teaching. You can look at previous outlines for a guide to the details of a unit.
| Session | MoA ? | Location | Outline ? |
|---|---|---|---|
|
Semester 2 2024
|
Online | Camperdown/Darlington, Sydney |
Outline unavailable
|
Modes of attendance (MoA)
This refers to the Mode of attendance (MoA) for the unit as it appears when you’re selecting your units in Sydney Student. Find more information about modes of attendance on our website.
